Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Change in Receivables (2020 - 2025)

GoHealth's Change in Receivables history spans 6 years, with the latest figure at -$141000.0 for Q3 2025.

  • For Q3 2025, Change in Receivables rose 98.36% year-over-year to -$141000.0; the TTM value through Sep 2025 reached -$6.9 million, up 12.48%, while the annual FY2024 figure was $2.2 million, 140.25% up from the prior year.
  • Change in Receivables for Q3 2025 was -$141000.0 at GoHealth, up from -$5.8 million in the prior quarter.
  • Across five years, Change in Receivables topped out at $22.9 million in Q1 2022 and bottomed at -$34.0 million in Q3 2022.
  • The 5-year median for Change in Receivables is $278000.0 (2022), against an average of -$920210.5.
  • The largest annual shift saw Change in Receivables surged 1277.97% in 2022 before it tumbled 4566.19% in 2023.
  • A 5-year view of Change in Receivables shows it stood at $8.9 million in 2021, then crashed by 96.89% to $278000.0 in 2022, then crashed by 4566.19% to -$12.4 million in 2023, then skyrocketed by 80.59% to -$2.4 million in 2024, then skyrocketed by 94.15% to -$141000.0 in 2025.
  • Per Business Quant, the three most recent readings for GOCO's Change in Receivables are -$141000.0 (Q3 2025), -$5.8 million (Q2 2025), and $1.4 million (Q1 2025).